Understanding cancer biology through protein analysis
CPTAC BIOSPECIMEN COLLECTION
['FUNDING_OTHER'] · LEIDOS BIOMEDICAL RESEARCH, INC. · NIH-10281342
This study is looking at the proteins in different types of cancer to learn more about how cancer grows, which could help doctors create better treatments for patients like you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | LEIDOS BIOMEDICAL RESEARCH, INC. (nih funded) |
| Locations | 1 site (FREDERICK, UNITED STATES) |
| Trial ID | NIH-10281342 on ClinicalTrials.gov |
What this research studies
This research focuses on improving our understanding of cancer by analyzing proteins and their modifications in various cancer types. By conducting detailed proteogenomic analyses, the project aims to identify key driver genes and understand how cancer develops at a molecular level. Patients may benefit from insights gained about the biological mechanisms of their cancers, which could lead to more targeted and effective treatments. The research involves collecting and analyzing biospecimens from cancer patients to explore these complex biological processes.
Who could benefit from this research
Good fit: Ideal candidates for participation are patients diagnosed with specific types of cancer who are willing to provide biospecimens for analysis.
Not a fit: Patients with non-malignant conditions or those not diagnosed with cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more precise cancer treatments tailored to the molecular characteristics of individual tumors.
How similar studies have performed: Previous research in proteogenomics has shown promise in enhancing our understanding of cancer biology and improving treatment strategies.
Where this research is happening
FREDERICK, UNITED STATES
- LEIDOS BIOMEDICAL RESEARCH, INC. — FREDERICK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: THIAGARAJAN, MATHANGI — LEIDOS BIOMEDICAL RESEARCH, INC.
- Study coordinator: THIAGARAJAN, MATHANGI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, neoplasm/cancer, Disease, Disorder